Description
Research Information
SYNERGY combines CJC-1295 No DAC and Ipamorelin.
CJC-1295 No DAC is studied in relation to growth hormone-releasing hormone signaling, while Ipamorelin is studied for activity at the growth hormone secretagogue receptor.
The combination provides a research model for investigating multiple signaling pathways involved in growth-hormone regulation.


Reviews
There are no reviews yet.